83 FR 5264 - Advisory Committee on Immunization Practices (ACIP)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 83, Issue 25 (February 6, 2018)

Page Range		5264-5265
FR Document		2018-02268

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public, limited only by room seating. Time will be available for public comment. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. The deadline for receipt is February 14, 2018. Written comments must include full name, address, organizational affiliation, email address of the speaker, topic being addressed and specific comments. Written comments must not exceed one single-spaced typed page with 1- inch margins containing all items above. Only those written comments received 10 business days in advance of the meeting will be included in the official record of the meeting. Public comments made in attendance must be no longer than 3 minutes and the person giving comments must attend the public comment session at the start time listed on the agenda. Time for public comments may start before the time indicated on the agenda. The meeting will be webcast live via the World Wide Web; for instructions and more information on ACIP please visit the ACIP website: http://www.cdc.gov/vaccines/acip/index.html.

Federal Register, Volume 83 Issue 25 (Tuesday, February 6, 2018)

[Federal Register Volume 83, Number 25 (Tuesday, February 6, 2018)]
[Notices]
[Pages 5264-5265]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-02268]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting of the Advisory Committee on Immunization Practices 
(ACIP). This meeting is open to the public, limited only by room 
seating. Time will be available for public comment. The public is 
welcome to submit written comments in advance of the meeting. Comments 
should be submitted in writing by email to the contact person listed 
below. The deadline for receipt is February 14, 2018. Written comments 
must include full name, address, organizational affiliation, email 
address of the speaker, topic being addressed and specific comments. 
Written comments must not exceed one single-spaced typed page with 1-
inch margins containing all items above. Only those written comments 
received 10 business days in advance of the meeting will be included in 
the official record of the meeting. Public comments made in attendance 
must be no longer than 3 minutes and the person giving comments must 
attend the public comment session at the start time listed on the 
agenda. Time for public comments may start before the time indicated on 
the agenda. The meeting will be webcast live via the World Wide Web; 
for instructions and more information on ACIP please visit the ACIP 
website: http://www.cdc.gov/vaccines/acip/index.html.

DATES: The meeting will be held on February 21, 2018, 8:00 a.m. to 5:45 
p.m., EDT, and February 22, 2018, 8:00 a.m. to 12:30 p.m. EDT.

ADDRESSES: CDC, 1600 Clifton Road, NE, Tom Harkin Global Communications 
Center, Kent `Oz' Nelson Auditorium, Atlanta, Georgia 30329.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, CDC, NCIRD. Email [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The committee is charged with advising the Director, CDC, 
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, 
the committee is mandated to establish and periodically review and, as 
appropriate, revise the

[[Page 5265]]

list of vaccines for administration to vaccine-eligible children 
through the Vaccines for Children (VFC) program, along with schedules 
regarding dosing interval, dosage, and contraindications to 
administration of vaccines. Further, under provisions of the Affordable 
Care Act, section 2713 of the Public Health Service Act, immunization 
recommendations of the ACIP that have been approved by the Director of 
the Centers for Disease Control and Prevention and appear on CDC 
immunization schedules must be covered by applicable health plans.
    Matters To Be Considered: The agenda will include discussions on 
Influenza vaccines, evidence based recommendations, anthrax vaccine, 
Japanese encephalitis vaccines, hepatitis vaccines, human 
papillomavirus vaccines, pneumococcal vaccines, meningococcal disease, 
and an update on vaccines and other biologics for prevention and 
treatment of healthcare-associated infections. A recommendation vote is 
scheduled for hepatitis vaccines and evidence based recommendations. 
Agenda items are subject to change as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-02268 Filed 2-5-18; 8:45 am]
 BILLING CODE 4163-18-P

5264 Federal Register / Vol. 83, No. 25 / Tuesday, February 6, 2018 / Notices

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
Number of Hours per Total burden
Form name responses per
respondents response hours
respondent

ICU Assessment .............................................................................................. 150 1 1.25 187.5
ICU Action Plan ............................................................................................... 150 1 2 300
Site Visits ......................................................................................................... 100 1 4 400

Total .......................................................................................................... 400 N/A N/A 887.5

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Average
Number of Total burden Total cost
Form name hourly wage
respondents hours burden
rate *

ICU Assessment Tool ...................................................................................... 150 187.5 a $52.58 $9,858.75
ICU Action Plan ............................................................................................... 150 300 a 52.58 15,774
Site Visits ......................................................................................................... 100 100 b 27.87 2,787
........................ 200 c 34.70 6,940
........................ 50 a 52.58 2,629
........................ 50 d 98.83 4,941.50

Total .......................................................................................................... 400 887.5 N/A 42,930.25
a Based on the mean wages for 11–9111 Medical and Health Services Managers.
b Based on the mean wages for 29–9099 Miscellaneous Health Practitioners and Technical Workers: Healthcare Practitioners and Technical
Workers, All Other.
c Based on the mean wages for 29–1141 Registered Nurse.
d Based on the mean wages for 29–1069 Physicians and Surgeons, All other.
National Compensation Survey: Occupational wages in the United States May 2016 ‘‘U.S. Department of Labor, Bureau of Labor Statistics:’’
http://www.bls.gov/oes/current/oes_stru.htm.

Request for Comments DEPARTMENT OF HEALTH AND received 10 business days in advance of
HUMAN SERVICES the meeting will be included in the
In accordance with the Paperwork official record of the meeting. Public
Reduction Act, comments on AHRQ’s Centers for Disease Control and comments made in attendance must be
information collection are requested Prevention no longer than 3 minutes and the person
with regard to any of the following: (a) giving comments must attend the public
Whether the proposed collection of Advisory Committee on Immunization comment session at the start time listed
information is necessary for the proper Practices (ACIP) on the agenda. Time for public
performance of AHRQ’s health care AGENCY: Centers for Disease Control and comments may start before the time
research and health care information Prevention (CDC), Department of Health indicated on the agenda. The meeting
dissemination functions, including and Human Services (HHS). will be webcast live via the World Wide
whether the information will have Web; for instructions and more
ACTION: Notice of meeting.
practical utility; (b) the accuracy of information on ACIP please visit the
AHRQ’s estimate of burden (including SUMMARY: In accordance with the ACIP website: http://www.cdc.gov/
hours and costs) of the proposed Federal Advisory Committee Act, the vaccines/acip/index.html.
collection(s) of information; (c) ways to Centers for Disease Control and DATES: The meeting will be held on
enhance the quality, utility and clarity Prevention (CDC), announces the February 21, 2018, 8:00 a.m. to 5:45
of the information to be collected; and following meeting of the Advisory p.m., EDT, and February 22, 2018, 8:00
(d) ways to minimize the burden of the Committee on Immunization Practices a.m. to 12:30 p.m. EDT.
collection of information upon the (ACIP). This meeting is open to the ADDRESSES: CDC, 1600 Clifton Road,
respondents, including the use of public, limited only by room seating. NE, Tom Harkin Global
automated collection techniques or Time will be available for public Communications Center, Kent ‘Oz’
other forms of information technology. comment. The public is welcome to Nelson Auditorium, Atlanta, Georgia
submit written comments in advance of 30329.
Comments submitted in response to the meeting. Comments should be
this notice will be summarized and submitted in writing by email to the FOR FURTHER INFORMATION CONTACT:
included in the Agency’s subsequent contact person listed below. The Stephanie Thomas, ACIP Committee
request for OMB approval of the deadline for receipt is February 14, Management Specialist, CDC, NCIRD.
proposed information collection. All 2018. Written comments must include Email ACIP@cdc.gov.
daltland on DSKBBV9HB2PROD with NOTICES

comments will become a matter of full name, address, organizational SUPPLEMENTARY INFORMATION:
public record. affiliation, email address of the speaker, Purpose: The committee is charged
Karen J. Migdail,
topic being addressed and specific with advising the Director, CDC, on the
comments. Written comments must not use of immunizing agents. In addition,
Chief of Staff.
exceed one single-spaced typed page under 42 U.S.C. 1396s, the committee is
[FR Doc. 2018–02289 Filed 2–5–18; 8:45 am] with 1-inch margins containing all items mandated to establish and periodically
BILLING CODE 4160–90–P above. Only those written comments review and, as appropriate, revise the

VerDate Sep<11>2014 19:02 Feb 05, 2018 Jkt 244001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\06FEN1.SGM 06FEN1

Federal Register / Vol. 83, No. 25 / Tuesday, February 6, 2018 / Notices 5265

list of vaccines for administration to one-day meeting, to be held on will now be held on Thursday, February
vaccine-eligible children through the Thursday, February 8, 2018. Agenda 8, 2018, from 8:30 a.m. to 3:00 p.m. ET.
Vaccines for Children (VFC) program, items have been updated and will
Amy McNulty,
along with schedules regarding dosing include a final evidence-based review
interval, dosage, and contraindications Acting Director, Division of the Executive
report on the spinal muscular atrophy Secretariat.
to administration of vaccines. Further, (SMA) condition nomination for
[FR Doc. 2018–02306 Filed 2–5–18; 8:45 am]
under provisions of the Affordable Care possible inclusion on the Recommended
Act, section 2713 of the Public Health BILLING CODE 4165–15–P
Uniform Screening Panel (RUSP).
Service Act, immunization Following this report, the ACHDNC
recommendations of the ACIP that have expects to vote on whether to DEPARTMENT OF HEALTH AND
been approved by the Director of the recommend adding SMA to the RUSP to HUMAN SERVICES
Centers for Disease Control and the Secretary of HHS. The agenda will
Prevention and appear on CDC also include presentation of a document National Institutes of Health
immunization schedules must be on cutoff determinations and risk
covered by applicable health plans. assessment methods used for dried National Institute on Minority Health
Matters To Be Considered: The agenda bloodspot newborn screening. The and Health Disparities; Notice of
will include discussions on Influenza Committee expects to vote on whether Closed Meeting
vaccines, evidence based to support this document. The ACHDNC
recommendations, anthrax vaccine, Pursuant to section 10(d) of the
members will also consider a report on Federal Advisory Committee Act, as
Japanese encephalitis vaccines, hepatitis
Quality Measures in Newborn Screening amended, notice is hereby given of the
vaccines, human papillomavirus
from the Follow up and Treatment following meeting.
vaccines, pneumococcal vaccines,
Workgroup. HRSA will post the agenda The meeting will be closed to the
meningococcal disease, and an update
two days prior to the meeting on the public in accordance with the
on vaccines and other biologics for
Committee’s website: https:// provisions set forth in sections
prevention and treatment of healthcare-
associated infections. A www.hrsa.gov/advisory-committees/ 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
recommendation vote is scheduled for heritable-disorders/index.html. Please as amended. The grant applications and
hepatitis vaccines and evidence based note that agenda items are subject to the discussions could disclose
recommendations. Agenda items are changes as priorities dictate. confidential trade secrets or commercial
subject to change as priorities dictate. DATES: Thursday, February 8, 2018, property such as patentable materials,
The Director, Management Analysis from 8:30 a.m. to 3:00 p.m. ET (meeting and personal information concerning
and Services Office, has been delegated time is tentative). individuals associated with the grant
the authority to sign Federal Register applications, the disclosure of which
notices pertaining to announcements of ADDRESSES: The address for the meeting would constitute a clearly unwarranted
meetings and other committee is 5600 Fishers Lane, 5th Floor Pavilion, invasion of personal privacy.
management activities, for both the Rockville, MD 20857. Participants may
Name of Committee: National Institute on
Centers for Disease Control and also access the meeting through Minority Health and Health Disparities
Prevention and the Agency for Toxic Webcast. Advanced registration is Special Emphasis Panel; Special Emphasis
Substances and Disease Registry. required. Please register online at http:// Panel (R13) Conferences Grants.
www.achdncmeetings.org/ by 12:00 p.m. Date: March 16, 2018.
Elaine L. Baker, Time: 1:00 p.m. to 4:00 p.m.
ET on February 5, 2018. Instructions on
Director, Management Analysis and Services how to access the meeting via Webcast Agenda: To review and evaluate grant
Office, Centers for Disease Control and applications.
will be provided upon registration.
Prevention. Place: National Institutes of Health
[FR Doc. 2018–02268 Filed 2–5–18; 8:45 am] Please note that the 5600 Fishers Lane NIMHD, 7201 Wisconsin Ave., Suite 533,
BILLING CODE 4163–18–P
building requires security screening on Bethesda, MD 20814.
entry. Visitors must provide a driver’s Contact Person: Richard C. Palmer, DRPH,
license, passport, or other form of Health Scientist Administrator, National
government-issued photo identification Institute on Minority Health and Health
DEPARTMENT OF HEALTH AND Disparities, National Institutes of Health,
HUMAN SERVICES or they cannot enter the facility. Per the 7201 Wisconsin Ave, Bethesda, MD 20814,
original meeting notice, non-US Citizens (301) 451–2432, richard.palmer@nih.gov.
Health Resources and Service planning to attend in person had to
Administration provide additional information to HRSA Dated: January 31, 2018.
by January 24, 2018, 12:00 p.m. Eastern David Clary,
Advisory Committee on Heritable Time. Program Analyst, Office of Federal Advisory
Disorders in Newborns and Children Committee Policy.
FOR FURTHER INFORMATION CONTACT: [FR Doc. 2018–02279 Filed 2–5–18; 8:45 am]
AGENCY: Health Resources and Service Anyone requesting information
Administration (HRSA), Department of BILLING CODE 4140–01–P
regarding the ACHDNC should contact
Health and Human Services (HHS). Ann Ferrero, Maternal and Child Health
ACTION: Notice; correction. Bureau (MCHB), HRSA, in one of three DEPARTMENT OF HEALTH AND
SUMMARY: This notice announces a ways: (1) Send a request to the following HUMAN SERVICES
daltland on DSKBBV9HB2PROD with NOTICES

correction to the meeting announcement address: Ann Ferrero, MCHB, HRSA
for a public meeting of the Advisory 5600 Fishers Lane, Room 18N100C, National Institutes of Health
Committee on Heritable Disorders in Rockville, MD 20857; (2) call 301–443–
3999; or (3) send an email to: AFerrero@ Center for Scientific Review; Notice of
Newborns and Children (ACHDNC), Closed Meetings
published in the Federal Register on hrsa.gov.
January 22, 2018. The meeting has Correction: Date and time of the Pursuant to section 10(d) of the
changed from a two-day meeting to a ACHDNC’s public meeting. The meeting Federal Advisory Committee Act, as

VerDate Sep<11>2014 19:02 Feb 05, 2018 Jkt 244001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\06FEN1.SGM 06FEN1

Document Created: 2018-02-06 00:30:27
Document Modified: 2018-02-06 00:30:27

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of meeting.
Dates		The meeting will be held on February 21, 2018, 8:00 a.m. to 5:45 p.m., EDT, and February 22, 2018, 8:00 a.m. to 12:30 p.m. EDT.
Contact		Stephanie Thomas, ACIP Committee Management Specialist, CDC, NCIRD. Email [email protected]
FR Citation		83 FR 5264

83 FR 5264 - Advisory Committee on Immunization Practices (ACIP)

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 83, Issue 25 (February 6, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention